Submitted for Publication: December 3, 2013; final revision received March 3, 2014; accepted March 28, 2014.
Published Online: June 11, 2014. doi:10.1001/jamapsychiatry.2014.680.
Study concept and design: Rando, Tuit, Sinha.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Van Dam, Rando, Sinha.
Critical revision of the manuscript for important intellectual content: Van Dam, Potenza, Tuit, Sinha.
Statistical analysis: Van Dam, Rando, Sinha.
Obtained funding: Potenza, Sinha.
Administrative, technical, or material support: Rando, Tuit, Sinha.
Study supervision: Tuit, Sinha.
Conflict of Interest Disclosures: Dr Potenza has consulted for and advised Boehringer Ingelheim; has consulted for and has financial interests in Somaxon; has received research support from the National Institutes of Health, Veterans Affairs, Mohegan Sun Casino, National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, Forest Laboratories, Psyadon, Ortho-McNeil, Oy-Control/Biotie, and GlaxoSmithKline; has participated in surveys, mailings, or telephone consultations related to drug addiction, impulse control disorders, or other health topics; has consulted for law offices and the federal public defender’s office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has given academic lectures in grand rounds, continuing medical education events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr Sinha is on the scientific advisory board for Embera NeuroTherapeutics.
Funding/Support: This work was supported by grants P50-DA016556 (Dr Sinha), R01-AA13892 (Dr Sinha), and RL1-AA017539 (Dr Potenza) from the National Institutes of Health, Roadmap Fund for Medical Research grants UL1-DE019586 (Dr Sinha), PL1-DA024859 (Dr Sinha), and UL1-RR024139 (Yale Clinical and Translational Science Award) from the National Institutes of Health, and the State of Connecticut Department of Mental Health and Addiction Services.
Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The contents of the article are the sole responsibility of the authors and do not necessarily represent the official views of any of the funding agencies.